Cat.#: ACPP-1206
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
| ACPP-1144 | Synthetic Nanodisc Human GIPR Protein (AC1144) | 10 µg | inquiry |
| ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg | inquiry |
| ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
| ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
| ACPP-1356 | GIRK2 Blocking Peptide (AC1356) | 250 µg | inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg | inquiry |
| ACPP-1811 | Human HSD17B8 Protein (AC1811) | 5 µg | inquiry |
| ACPP-1675 | Human TOR1A Protein (AC1675) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.